HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Lorenzo Belluomini Selected Research
Lorenzo Belluomini Research Topics
Disease
14
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 11/2018
13
Neoplasms (Cancer)
04/2024 - 11/2019
10
Lung Neoplasms (Lung Cancer)
03/2024 - 11/2018
2
Breast Neoplasms (Breast Cancer)
03/2024 - 09/2023
2
Infections
01/2024 - 12/2020
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2023 - 10/2022
2
Inflammation (Inflammations)
01/2023 - 11/2021
2
Adenocarcinoma of Lung
08/2022 - 01/2022
1
Head and Neck Neoplasms (Head and Neck Cancer)
11/2023
1
Melanoma (Melanoma, Malignant)
09/2023
1
Disease Progression
08/2022
1
Adenocarcinoma
01/2022
1
Post-Acute COVID-19 Syndrome
01/2022
1
Lung Diseases (Lung Disease)
08/2021
1
Cachexia
01/2021
1
Death (Near-Death Experience)
01/2021
1
Virus Diseases (Viral Diseases)
12/2020
1
COVID-19
12/2020
1
Hepatitis B
12/2020
1
Communicable Diseases (Infectious Diseases)
12/2020
1
Bacterial Infections (Bacterial Infection)
12/2020
1
Dysbiosis
12/2020
1
Stomach Neoplasms (Stomach Cancer)
02/2018
Drug/Important Bio-Agent (IBA)
5
pembrolizumab
IBA
03/2024 - 06/2019
5
Immune Checkpoint Inhibitors
IBA
11/2023 - 11/2018
5
Nivolumab
IBA
01/2023 - 11/2018
3
Platinum
IBA
03/2024 - 01/2020
3
Biomarkers (Surrogate Marker)
IBA
11/2023 - 01/2022
2
Pemetrexed (MTA)
FDA Link
03/2024 - 01/2022
2
Immunoconjugates (Immunoconjugate)
IBA
11/2023 - 04/2023
2
Ligands
IBA
11/2023 - 06/2019
2
Hormones (Hormone)
IBA
09/2023 - 11/2021
2
Tyrosine Kinase Inhibitors
IBA
04/2023 - 01/2022
2
Cell-Free Nucleic Acids
IBA
08/2022 - 06/2021
2
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 01/2022
1
Carboplatin (JM8)
FDA Link
Generic
03/2024
1
4-amino-4'-hydroxylaminodiphenylsulfone (HADS)
IBA
01/2024
1
Vaccines
IBA
01/2024
1
sacituzumab govitecan
IBA
11/2023
1
Imatinib Mesylate (Gleevec)
FDA Link
09/2023
1
osimertinib
IBA
09/2023
1
Surface Antigens (Surface Antigen)
IBA
04/2023
1
RNA (Ribonucleic Acid)
IBA
08/2022
1
selpercatinib
IBA
01/2022
1
Smoke
IBA
01/2022
1
Gold
IBA
01/2022
1
Messenger RNA (mRNA)
IBA
06/2021
1
Anti-Bacterial Agents (Antibiotics)
IBA
12/2020
1
Afatinib
IBA
01/2020
1
durvalumab
IBA
06/2019
1
atezolizumab
IBA
06/2019
1
Programmed Cell Death 1 Receptor
IBA
06/2019
1
Trastuzumab (Herceptin)
FDA Link
02/2018
Therapy/Procedure
11
Therapeutics
03/2024 - 11/2019
7
Immunotherapy
03/2024 - 11/2019
4
Radiotherapy
01/2022 - 11/2018
3
Preoperative Exercise
04/2024 - 08/2021
2
Precision Medicine
01/2022 - 01/2021
2
Drug Therapy (Chemotherapy)
01/2022 - 01/2020
1
Length of Stay
04/2024
1
Resistance Training
03/2024
1
Immunomodulation
01/2022
1
Preoperative Period
08/2021